SCOPUS 정보 검색 플랫폼

Nature Biotechnology

Volumn 20, Issue 11, 2002, Pages 1085-1089

Value drivers in licensing deals

(6) Arnold, Katie a Coia, Anthony b Saywell, Scott c Smith, Ty d Minick, Scott a Löffler, Alicia e

a BOSTON SCIENTIFIC CORPORATION (United States)

b LEK Consulting (United States)

c Genitope Corporation (United States)

d First Genetic Trust (United States)

e NORTHWESTERN UNIVERSITY (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BEHAVIORAL RESEARCH;

NEGOTIATORS;

BIOTECHNOLOGY;

BIOTECHNOLOGY; COMMERCIAL PHENOMENA; DATA ANALYSIS; INVESTMENT; LICENSING; MANAGER; MARKETING; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; ARTICLE; COMPARATIVE STUDY; COOPERATION; COST BENEFIT ANALYSIS; DRUG INDUSTRY; ECONOMICS; EVALUATION; EXPERT WITNESS; INCOME; METHODOLOGY; STATISTICS; UNITED STATES; UTILIZATION REVIEW;

BIOTECHNOLOGY; COMMERCE; COOPERATIVE BEHAVIOR; COST-BENEFIT ANALYSIS; DRUG INDUSTRY; ENTREPRENEURSHIP; EXPERT TESTIMONY; INCOME; LICENSURE; UNITED STATES;

EID: 0036842612 PISSN: 10870156 EISSN: None Source Type: Journal
DOI: 10.1038/nbt1102-1085 Document Type: Review

Times cited : (23)

References (8)

1
- 85006315314
- Recombinant Capital. http://www.recap.com

2
- 2142812520
- Burrill & Co, San Francisco, CA
- Burrill, S. Biotech 2002: Life Sciences: System Biology Industry Report (Burrill & Co, San Francisco, CA, 2002).
- (2002) Biotech 2002: Life Sciences: System Biology Industry Report
- Burrill, S.¹

3
- 33645428377
- National Bureau of Economic Research. Working Paper w9007 (January 2002)
- Nicholson, S., Danzon, RM., & McCullough, J. Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality. National Bureau of Economic Research. Working Paper w9007 (January 2002), http://www.nber.org/papers/w9007.
- Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality
- Nicholson, S.¹ Danzon, R.M.² McCullough, J.³

4
- 0001538752
- R&D rivalry with licensing or imitation
- Katz, M. & Shapiro, C. R&D rivalry with licensing or imitation. Am. Econ. Rev. 77, 402 (1997).
- (1997) Am. Econ. Rev. , vol.77 , pp. 402
- Katz, M.¹ Shapiro, C.²

5
- 0003406828
- W.W. Norton & Co., NewYork
- Waterman, R. What America Does Right: Learning from Companies that Put People First (W.W. Norton & Co., NewYork, 1994).
- (1994) What America Does Right: Learning from Companies that Put People First
- Waterman, R.¹

6
- 0004176438
- Oxford University Press, Oxford, UK
- Teece, D. Managing Intellectual Capital, Organizational, Strategic and Policy Dimensions. (Oxford University Press, Oxford, UK, 2000).
- (2000) Managing Intellectual Capital, Organizational, Strategic and Policy Dimensions
- Teece, D.¹

7
- 0030854938
- Biotechnology valuation: The guiding principles behind the financial exercise that some view as an art form
- Persidis, A & Menzel, G, Biotechnology valuation: The guiding principles behind the financial exercise that some view as an art form. Nat. Biotechnol. 15, 813 (1997).
- (1997) Nat. Biotechnol. , vol.15 , pp. 813
- Persidis, A.¹ Menzel, G.²

8
- 0034865742
- Putting a price on biotechnology
- Stewart, J., Allison, P., & Johnson, R. Putting a price on biotechnology. Nat. Biotechnol. 19, 813 (2001).
- (2001) Nat. Biotechnol. , vol.19 , pp. 813
- Stewart, J.¹ Allison, P.² Johnson, R.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.